Cargando…

Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. stems: an investigation by in silico and in vitro studies

INTRODUCTION: Bioactive compounds from traditional medicines are good alternatives to standard diabetes therapies and may lead to new therapeutic discoveries. The stems of Bauhinia strychnifolia Craib. (BC) have a possible antihyperglycemic effect; However, the extraction of astilbin from BC has nev...

Descripción completa

Detalles Bibliográficos
Autores principales: Eawsakul, Komgrit, Ongtanasup, Tassanee, Ngamdokmai, Ngamrayu, Bunluepuech, Kingkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885589/
https://www.ncbi.nlm.nih.gov/pubmed/36717857
http://dx.doi.org/10.1186/s12906-023-03857-5
_version_ 1784879960053252096
author Eawsakul, Komgrit
Ongtanasup, Tassanee
Ngamdokmai, Ngamrayu
Bunluepuech, Kingkan
author_facet Eawsakul, Komgrit
Ongtanasup, Tassanee
Ngamdokmai, Ngamrayu
Bunluepuech, Kingkan
author_sort Eawsakul, Komgrit
collection PubMed
description INTRODUCTION: Bioactive compounds from traditional medicines are good alternatives to standard diabetes therapies and may lead to new therapeutic discoveries. The stems of Bauhinia strychnifolia Craib. (BC) have a possible antihyperglycemic effect; However, the extraction of astilbin from BC has never been recorded in alpha-glucosidase inhibitory activities. METHODS: Using liquid chromatography–mass spectrometry (LC–MS/MS), 32 compounds were detected in the BC extract. The screening was based on peak area. Seven compounds found. PASS recognized all seven compounds as potential alpha-glucosidase (AG) inhibitors. Astilbin and quercetin 3-rhamnoside were the most likely inhibitors of AG. Arguslab, AutoDock, and AutoDock Vina investigated the binding of the two compounds and AG. The binding stability was confirmed by molecular dynamics (MD). In addition, the optimum solvent extraction was studied via CosmoQuick, and extracts were examined with (1)H-NMR prior to testing with AG. RESULTS: All three software programs demonstrated that both compounds inhibit AG more effectively than acarbose. According to the sigma profile, THF is recommended for astilbin extraction. The BC extract with THF showed outstanding AG inhibitory action with an IC(50) of 158 ± 1.30 µg mL-1, which was much lower than that of the positive control acarbose (IC(50) = 190 ± 6.97 µg mL-1). In addition, astilbin from BC was found to inhibit AG strongly, IC50 = 22.51 ± 0.70 µg mL-1 through the extraction method of large-scale astilbin with THF has the best extraction capacity compared to other solvents, hence the initial stage of extraction employs THF to extract and precipitate them with ethyl acetate and water. CONCLUSION: In silico and in vitro studies reveal that astilbin inhibits AG and is superior to acarbose, validating its promise as an AG inhibitor. Overall, astilbin was the most bioactive component of BC for antidiabetic action.
format Online
Article
Text
id pubmed-9885589
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98855892023-01-31 Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. stems: an investigation by in silico and in vitro studies Eawsakul, Komgrit Ongtanasup, Tassanee Ngamdokmai, Ngamrayu Bunluepuech, Kingkan BMC Complement Med Ther Research INTRODUCTION: Bioactive compounds from traditional medicines are good alternatives to standard diabetes therapies and may lead to new therapeutic discoveries. The stems of Bauhinia strychnifolia Craib. (BC) have a possible antihyperglycemic effect; However, the extraction of astilbin from BC has never been recorded in alpha-glucosidase inhibitory activities. METHODS: Using liquid chromatography–mass spectrometry (LC–MS/MS), 32 compounds were detected in the BC extract. The screening was based on peak area. Seven compounds found. PASS recognized all seven compounds as potential alpha-glucosidase (AG) inhibitors. Astilbin and quercetin 3-rhamnoside were the most likely inhibitors of AG. Arguslab, AutoDock, and AutoDock Vina investigated the binding of the two compounds and AG. The binding stability was confirmed by molecular dynamics (MD). In addition, the optimum solvent extraction was studied via CosmoQuick, and extracts were examined with (1)H-NMR prior to testing with AG. RESULTS: All three software programs demonstrated that both compounds inhibit AG more effectively than acarbose. According to the sigma profile, THF is recommended for astilbin extraction. The BC extract with THF showed outstanding AG inhibitory action with an IC(50) of 158 ± 1.30 µg mL-1, which was much lower than that of the positive control acarbose (IC(50) = 190 ± 6.97 µg mL-1). In addition, astilbin from BC was found to inhibit AG strongly, IC50 = 22.51 ± 0.70 µg mL-1 through the extraction method of large-scale astilbin with THF has the best extraction capacity compared to other solvents, hence the initial stage of extraction employs THF to extract and precipitate them with ethyl acetate and water. CONCLUSION: In silico and in vitro studies reveal that astilbin inhibits AG and is superior to acarbose, validating its promise as an AG inhibitor. Overall, astilbin was the most bioactive component of BC for antidiabetic action. BioMed Central 2023-01-30 /pmc/articles/PMC9885589/ /pubmed/36717857 http://dx.doi.org/10.1186/s12906-023-03857-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Eawsakul, Komgrit
Ongtanasup, Tassanee
Ngamdokmai, Ngamrayu
Bunluepuech, Kingkan
Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. stems: an investigation by in silico and in vitro studies
title Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. stems: an investigation by in silico and in vitro studies
title_full Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. stems: an investigation by in silico and in vitro studies
title_fullStr Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. stems: an investigation by in silico and in vitro studies
title_full_unstemmed Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. stems: an investigation by in silico and in vitro studies
title_short Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. stems: an investigation by in silico and in vitro studies
title_sort alpha-glucosidase inhibitory activities of astilbin contained in bauhinia strychnifolia craib. stems: an investigation by in silico and in vitro studies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885589/
https://www.ncbi.nlm.nih.gov/pubmed/36717857
http://dx.doi.org/10.1186/s12906-023-03857-5
work_keys_str_mv AT eawsakulkomgrit alphaglucosidaseinhibitoryactivitiesofastilbincontainedinbauhiniastrychnifoliacraibstemsaninvestigationbyinsilicoandinvitrostudies
AT ongtanasuptassanee alphaglucosidaseinhibitoryactivitiesofastilbincontainedinbauhiniastrychnifoliacraibstemsaninvestigationbyinsilicoandinvitrostudies
AT ngamdokmaingamrayu alphaglucosidaseinhibitoryactivitiesofastilbincontainedinbauhiniastrychnifoliacraibstemsaninvestigationbyinsilicoandinvitrostudies
AT bunluepuechkingkan alphaglucosidaseinhibitoryactivitiesofastilbincontainedinbauhiniastrychnifoliacraibstemsaninvestigationbyinsilicoandinvitrostudies